ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR
申请人:Buchmann Bernd
公开号:US20090023741A1
公开(公告)日:2009-01-22
The present invention relates to aryl/hetarylamide derivatives of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP
2
receptor.
[EN] ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR<br/>[FR] ARYL/HÉTARYLAMIDES EN TANT QUE MODULATEURS DU RÉCEPTEUR EP2
申请人:BAYER SCHERING PHARMA AG
公开号:WO2008152099A2
公开(公告)日:2008-12-18
[EN] The present invention relates to aryl/ hetarylamide derivativ es of the general formula (I), process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP2 receptor. [FR] La présente invention porte sur des dérivés d'aryle/hétarylamide de la formule générale (I), sur un procédé pour leur préparation et sur l'utilisation de ceux-ci dans la fabrication de compositions pharmaceutiques pour le traitement de troubles et d'indications associés au récepteur EP2.
Chalcogen bond-assisted syn-locked scaffolds: DFT analysis and biological implications of novel tubulin inhibitors